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LETTERS TO THE EDITOR
Podocin mutations in
sporadic focal-segmental
glomerulosclerosis occurring
in adulthood
To the Editor: Podocin is a key component of the podo-
cyte slit diaphragm. Mutations of podocin cause recessive
steroid-resistant nephrotic syndrome that evolves to renal
failure in early childhood [1]. They have also been found
in children with sporadic nephrotic syndrome [2] and vari-
able outcome including patients with steroid and cyclospo-
rine sensitivity [3].
Herein, we present the results of podocin mutation
screening in 64 adults with steroid resistant nephrotic syn-
drome, showing the presence of heterozygous mutation
in three. Two were new mutations [i.e., S211T and H325Y
(Fig. 1)]; the remaining one (i.e., P20L) was frequently
Fig. 1. Electropherogram of two new podocin mutations. Conservationobserved in children. New mutations determine an amino of the mutated amino acids through species is also reported.
acid change in exon 5 (nucleotide 631 T-A) and exon
8 (nucleotide 973 C-T), respectively, being the wild-type
conserved in mouse and rat (Fig. 1). Clinical features were
REFERENCEScomparable in the three patients. All were unresponsive
1. Boute N, Gribouval O, Roselli S, et al: NPHS2, encoding theto drugs (steroids and cyclosporine) and progressed to
glomerular protein podocin, is mutated in autosomal recessive steroid-end-stage renal failure. Age at onset of proteinuria varied resistant nephrotic syndrome. Nat Genet 24:349–354, 2000
from 21 and 34 years in the case of H325Y and S211T, 2. Caridi G, Bertelli R, Carrea A, et al: Prevalence, genetics, and
clinical features of patients carrying podocin mutations in steroid-respectively, and to 60 years of the patient with the P20L.
resistant nonfamilial focal segmental glomerulosclerosis. J Am SocFocal-segmental glomerulosclerosis (FSGS) was present Nephrol 12:2742–2746, 2001
3. Caridi G, Bertelli R, Di Duca M, et al: Broadening the spectrumin the two patients for whom a renal biopsy was available
of diseases related to podocin mutations. J Am Soc Nephrol, 2003(H325Y and S211T). The same two patients received a
renal transplant and recurrence occurred in one patient.
These data describe podocin mutations in adults with
FSGS and confirm the association with a wide range of Mycophenolate mofetil
clinical characteristics. Molecular analysis of podocin
should be extended to adults with FSGS since may modify prevents development of
the therapeutic approach in these patients.
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